Bausch Health
289 hedge funds and large institutions have $2.48B invested in Bausch Health in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 93 increasing their positions, 86 reducing their positions, and 55 closing their positions.
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
8% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 86
0.95% less ownership
Funds ownership: 50.93% → 49.98% (-0.95%)
9% less funds holding
Funds holding: 317 → 289 (-28)
19% less capital invested
Capital invested by funds: $3.06B → $2.48B (-$581M)
44% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 55
54% less call options, than puts
Call options by funds: $257M | Put options by funds: $561M
Top Buyers
Top Sellers
BHC Hedge Fund Activity: Q3 2017 in Review
289 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2017, worth a combined $2.48B — down 19% from $3.06B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of BHC and 31 opened new positions — a net loss of 24 holders — while 86 trimmed existing stakes and 93 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $51.8M. The largest seller was Toronto Dominion Bank, cutting an estimated $168M.
- 289 institutional investors held Bausch Health (BHC) as of Q3 2017, down from 317 in Q2 2017.
- Funds reported $2.48B of Bausch Health stock for Q3 2017, down 19% quarter-over-quarter.
- 31 funds opened new Bausch Health positions in Q3 2017 and 55 closed out, a net change of -24 holders.
- The largest Bausch Health buyer in Q3 2017 was Dimensional Fund Advisors, an estimated $51.8M added.
- The largest Bausch Health seller in Q3 2017 was Toronto Dominion Bank, an estimated $168M sold.
Based on aggregated 13F filings for Q3 2017.